| ADCC | Antibody-dependent cellular cytotoxicity |
| BC | Breast cancer |
| DFS | Disease-free survival |
| EBC | Early breast cancer |
| HR | Hazard ratio |
| LABC | Locally advanced breast cancer |
| MoAb | Monoclonal Antibody |
| MBC | Metastatic breast cancer |
| ORR | Objective response rate |
| OS | Overall survival |
| PARPi | Poly [ADP-ribose] polymerase inhibitor |
| pCR | Pathologic complete response |
| PFS | Progression-free survival |
| RFS | Relapse-free survival |
| TKi | Thymidine kinase inhibitor |
| TNBC | Triple-Negative Breast Cancer |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.